These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 18416448)

  • 81. Statistical inference for clinical trials with binary responses when there is a shift in patient population.
    Yang LY; Chi Y; Chow SC
    J Biopharm Stat; 2011 May; 21(3):437-52. PubMed ID: 21442518
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Performance of adaptive sample size adjustment with respect to stopping criteria and time of interim analysis.
    Jahn-Eimermacher A; Hommel G
    Stat Med; 2007 Mar; 26(7):1450-61. PubMed ID: 16900553
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Statistical sampling and hypothesis testing in orthopaedic research.
    Bernstein J; McGuire K; Freedman KB
    Clin Orthop Relat Res; 2003 Aug; (413):55-62. PubMed ID: 12897596
    [TBL] [Abstract][Full Text] [Related]  

  • 84. A generalized concept of power helped to choose optimal endpoints in clinical trials.
    Borm GF; van der Wilt GJ; Kremer JA; Zielhuis GA
    J Clin Epidemiol; 2007 Apr; 60(4):375-81. PubMed ID: 17346612
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Methods for one-sided testing of the difference between proportions and sample size considerations related to non-inferiority clinical trials.
    Dann RS; Koch GG
    Pharm Stat; 2008; 7(2):130-41. PubMed ID: 17526060
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Sequential analysis of latent variables using mixed-effect latent variable models: Impact of non-informative and informative missing data.
    Sébille V; Hardouin JB; Mesbah M
    Stat Med; 2007 Nov; 26(27):4889-904. PubMed ID: 17576119
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Sample size calculation for an agreement study.
    Liao JJ
    Pharm Stat; 2010; 9(2):125-32. PubMed ID: 19507134
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Designing and analyzing clinical trials which allow institutions to randomize patients to a subset of the treatments under study.
    Schoenfeld DA; Gelber RD
    Biometrics; 1979 Dec; 35(4):825-9. PubMed ID: 526527
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Sample sizes and negative studies in clinical vaccine research.
    Jacobson RM; Poland GA
    Vaccine; 2005 Mar; 23(17-18):2318-21. PubMed ID: 15755619
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Sample sizes in the multivariate analysis of repeated measurements.
    Vonesh EF; Schork MA
    Biometrics; 1986 Sep; 42(3):601-10. PubMed ID: 3567293
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Power and sample size determination when assessing the clinical relevance of trial results by 'responder analyses'.
    Kieser M; Röhmel J; Friede T
    Stat Med; 2004 Nov; 23(21):3287-305. PubMed ID: 15490433
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Power and sample size calculations for current status survival analysis.
    Williamson JM; Lin HM; Kim HY
    Stat Med; 2009 Jul; 28(15):1999-2011. PubMed ID: 19455509
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Simple procedures for blinded sample size adjustment that do not affect the type I error rate.
    Kieser M; Friede T
    Stat Med; 2003 Dec; 22(23):3571-81. PubMed ID: 14652861
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Sample size for two-stage studies with maintenance therapy.
    Feng W; Wahed AS
    Stat Med; 2009 Jul; 28(15):2028-41. PubMed ID: 19382105
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Sample size in clinical trials with dichotomous endpoints: use of covariables.
    Choi SC
    J Biopharm Stat; 1998 Jul; 8(3):367-75. PubMed ID: 9741853
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Back to basics: explaining sample size in outcome trials, are statisticians doing a thorough job?
    Carroll KJ
    Pharm Stat; 2009; 8(4):333-45. PubMed ID: 19180520
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Studies of equivalence in clinical vaccine research.
    Jacobson RM; Poland GA
    Vaccine; 2005 Mar; 23(17-18):2315-7. PubMed ID: 15755618
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Statistical significance, power and sample size--Part 2.
    Christley RM
    J Small Anim Pract; 2008 Jul; 49(7):321-2. PubMed ID: 18638056
    [No Abstract]   [Full Text] [Related]  

  • 99. Sample size calculations for comparative clinical trials with over-dispersed Poisson process data.
    Matsui S
    Stat Med; 2005 May; 24(9):1339-56. PubMed ID: 15568188
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Bayesian sample size for exploratory clinical trials incorporating historical data.
    Whitehead J; Valdés-Márquez E; Johnson P; Graham G
    Stat Med; 2008 Jun; 27(13):2307-27. PubMed ID: 18069728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.